A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials

dc.contributor.authorSola Llopis, Susana de
dc.contributor.authorTorre Fornell, Rafael de la
dc.contributor.authorSánchez Benavides, Gonzalo
dc.contributor.authorBenejam, Bessy
dc.contributor.authorCuenca Royo, Aida
dc.contributor.authorHoyo, Laura del
dc.contributor.authorRodríguez, Joan
dc.contributor.authorCatuara-Solarz, Silvina
dc.contributor.authorSanchez-Gutierrez, Judit
dc.contributor.authorDueñas Espín, Ivan
dc.contributor.authorHernandez, Gimena
dc.contributor.authorPeña-Casanova, Jordi
dc.contributor.authorLangohr, Klaus
dc.contributor.authorVidela, Sebastià
dc.contributor.authorBlehaut, Henry
dc.contributor.authorFarré Albaladejo, Magí
dc.contributor.authorDierssen, Mara
dc.contributor.authorTESDAD Study Group
dc.date.accessioned2020-11-18T11:10:46Z
dc.date.available2020-11-18T11:10:46Z
dc.date.issued2015-06-04
dc.date.updated2020-11-18T11:10:46Z
dc.description.abstractThe recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological challenges and questioned the prevailing methodology used to evaluate cognitive functioning of DS individuals. This is usually achieved by comparing DS individuals to matched healthy controls of the same mental age. We propose a new tool, the TESDAD Battery that uses comparison with age-matched typically developed adults. This is an advantageous method for probing the clinical efficacy of DS therapies, allowing the interpretation and prediction of functional outcomes in clinical trials. In our DS population the TESDAD battery permitted a quantitative assessment of cognitive defects, which indicated language dysfunction and deficits in executive function, as the most important contributors to other cognitive and adaptive behavior outcomes as predictors of functional change in DS. Concretely, auditory comprehension and functional academics showed the highest potential as end-point measures of therapeutic intervention for clinical trials: the former as a cognitive key target for therapeutic intervention, and the latter as a primary functional outcome measure of clinical efficacy. Our results also emphasize the need to explore the modulating effects of IQ, gender and age on cognitive enhancing treatments. Noticeably, women performed significantly better than men of the same age and IQ in most cognitive tests, with the most consistent differences occurring in memory and executive functioning and negative trends rarely emerged on quality of life linked to the effect of age after adjusting for IQ and gender. In sum, the TESDAD battery is a useful neurocognitive tool for probing the clinical efficacy of experimental therapies in interventional studies in the DS population suggesting that age-matched controls are advantageous for determining normalization of DS.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec699731
dc.identifier.issn1664-1078
dc.identifier.pmid26089807
dc.identifier.urihttps://hdl.handle.net/2445/172191
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fpsyg.2015.00708
dc.relation.ispartofFrontiers in Psychology, 2015, vol. 6, p. 708
dc.relation.urihttps://doi.org/10.3389/fpsyg.2015.00708
dc.rightscc-by (c) Sola Llopis, Susana de et al., 2015
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject.classificationSíndrome de Down
dc.subject.classificationAssaigs clínics
dc.subject.classificationCognició
dc.subject.otherDown syndrome
dc.subject.otherClinical trials
dc.subject.otherCognition
dc.titleA new cognitive evaluation battery for Down syndrome and its relevance for clinical trials
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
699731.pdf
Mida:
1.01 MB
Format:
Adobe Portable Document Format